SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Danielsson Rolf) "

Sökning: WFRF:(Danielsson Rolf)

  • Resultat 1-10 av 71
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  •  
2.
  • Bergquist, Annika, et al. (författare)
  • Increased risk of primary sclerosing cholangitis and ulcerative colitis in first-degree relatives of patients with primary sclerosing cholangitis
  • 2008
  • Ingår i: Clinical Gastroenterology and Hepatology. - New York : Elsevier. - 1542-3565 .- 1542-7714. ; 6:8, s. 939-943
  • Tidskriftsartikel (refereegranskat)abstract
    • Background & Aims: The importance of genetic factors for the development of primary sclerosing cholangitis (PSC) is incompletely understood. This study assessed the risk of PSC and inflammatory bowel disease (IBD) among first-degree relatives of patients with PSC, compared with the first-degree relatives of a cohort without PSC. Methods: Subjects from the national Swedish cohort of PSC patients (n = 678) were matched for date of birth, sex, and region to up to 10 subjects without a diagnosis of PSC (n = 6347). Linkage through general population registers identified first-degree relatives of subjects in both the PSC and comparison cohorts (n = 34,092). Diagnoses among first-degree relatives were identified by using the Inpatient Register. Results: The risk of cholangitis was statistically significantly increased in offspring, siblings, and parents of the PSC patient cohort, compared with relatives of the comparison cohort, with the hazard ratios and 95% confidence intervals, 11.5 (1.6–84.4), 11.1 (3.3–37.8), and 2.3 (0.9–6.1), respectively. The hazard ratios for ulcerative colitis (UC) among first-degree relatives of all PSC patients was 3.3 (2.3–4.9) and for Crohn's disease 1.4 (0.8–2.5). The risk of UC for relatives of PSC patients without IBD was also increased, 7.4 (2.9–18.9). Conclusions: First-degree relatives of patients with PSC run an increased risk of PSC, indicating the importance of genetic factors in the etiology of PSC. First-degree relatives of PSC patients without IBD are also at an increased risk of UC, which might indicate shared genetic susceptibility factors for PSC and UC. 
  •  
3.
  • Löfberg, Robert, et al. (författare)
  • Oral budesonide versus prednisolone in patients with extensive and left sided ulcerative colitis
  • 1996
  • Ingår i: Gastroenterology. - : Elsevier BV. - 1528-0012 .- 0016-5085. ; 110:6, s. 1713-1718
  • Tidskriftsartikel (refereegranskat)abstract
    • BACKGROUND & AIMS: Systemic glucocorticosteroids (GCSs) have proven efficacy in active ulcerative colitis but cause undesired systemic side effects. Therefore, new GCSs with high topical activity and a high rate of metabolism may be of clinical value in this condition. The aim of this study was to explore the efficacy and safety of the topically acting GCS budesonide in an oral controlled-release formulation in extensive or left-sided, mild to moderately active ulcerative colitis. METHODS: A 9-week, randomized, double-blind, controlled trial was performed, and treatments with 10 mg budesonide or 40 mg prednisolone daily, both gradually tapered, were compared. Endoscopic improvement and effect on endogenous plasma cortisol were assessed. RESULTS: Thirty-four patients were administered budesonide, and 38 patients were administered prednisolone. Mean endoscopic scores improved significantly in both groups but without difference between the groups. Five patients in the budesonide group and 7 patients in the prednisolone group deteriorated and were withdrawn from the study. Morning plasma cortisol levels were suppressed in the prednisolone group (entry, 449 nmol/L; 2 weeks, 116 nmol/L; 4 weeks, 195 nmol/L) but were unchanged in the budesonide group. CONCLUSIONS: The GCS budesonide administered in an oral controlled-release formulation seems to give an overall treatment result in active ulcerative colitis approaching that of prednisolone but without suppression of plasma cortisol levels. This concept merits further evaluation.
  •  
4.
  •  
5.
  •  
6.
  • Aleman, Soo, et al. (författare)
  • Health check-ups and family screening allow detection of hereditary hemochromatosis with less advanced liver fibrosis and survival comparable with the general population
  • 2011
  • Ingår i: Scandinavian Journal of Gastroenterology. - : Informa UK Limited. - 0036-5521 .- 1502-7708. ; 46:9, s. 1118-1126
  • Tidskriftsartikel (refereegranskat)abstract
    • Objective. The information concerning the morbidity and mortality of hereditary hemochromatosis is based primarily on clinical cohorts of symptomatic patients. The major aim of this study was to analyze the long-term prognosis for Swedish patients with this condition, with respect to both clinical features and survival, in relation to the route by which the disease was detected. Patients and methods. 373 patients with hemochromatosis detected through routine health checkups (n = 153), family screening (n = 44), symptoms of arthralgia (n = 23), investigation of other diseases/symptoms (n = 108) or signs of liver disease (n = 45) were monitored for a mean period of 11.9 +/- 5.8 years. The degree of liver fibrosis and survival were analyzed. Results. Overall survival among these patients was not significantly different from that of a matched normal population. The patients diagnosed through health check-ups and family screening were detected at an earlier age and had the highest rate of survival. Liver biopsy at the time of diagnosis revealed cirrhosis in 9% of those detected through the health check-ups and 5% in the case of family screening, compared with 13% for the group with arthralgia, 17% for other diseases/symptoms and 42% for liver disease. Conclusion. Health check-ups and family screening allow detection of hereditary hemochromatosis at an earlier age and with less advanced liver fibrosis, although a few of these patients have already developed cirrhosis. Our study indicates that iron indices should be included in health check-ups, and if abnormal, should lead to further investigation.
  •  
7.
  • Allard, Erik, et al. (författare)
  • Comparing capillary electrophoresis : mass spectrometry fingerprints of urine samples obtained after intake of coffee, tea, or water.
  • 2008
  • Ingår i: Analytical Chemistry. - : American Chemical Society (ACS). - 0003-2700 .- 1520-6882. ; 80:23, s. 8946-8955
  • Tidskriftsartikel (refereegranskat)abstract
    • Metabolomic fingerprinting is a growing strategy for characterizing complex biological samples without detailed prior knowledge about the metabolic system. A two-way analysis system with liquid separation and mass spectrometric detection provides detail-rich data suitable for such fingerprints. As a model study, human urine samples, obtained after intake of coffee, tea, or water, were analyzed with capillary electrophoresis electrospray ionization time-of-flight mass spectrometry (CE−ESI-TOF-MS). In-house-developed software (in Matlab) was utilized to manage and explore the large amount of data acquired (230 CE−MS runs, each with 50−100 million nonzero data points). After baseline and noise reduction, followed by suitable binning in time and m/z, the data sets comprised 9 and 14 million data points in negative and positive ESI mode, respectively. Finally, a signal threshold was applied, further reducing the number to about 100 000 data points per data set. A set of interactive exploratory tools, utilizing principal component analysis (PCA) and analysis of variance (ANOVA) results based on a general linear model, facilitated visual interpretation with score plots (for group assessment) and differential fingerprints (for “hot spot” detection). In the model study highly significant differences due to beverage intake were obtained among the 10 first principal components (p < 10−6 for two of the components in both ESI modes). Especially, the contrasts between “coffee” and “tea or water” indicated several “hot spots” with highly elevated intensities (e.g., for uncharged masses 93, 94, 109, 119, 123, 132, 148, 169, 178, 187, 190, and 193) suitable for further analysis, for example, with tandem MS.
  •  
8.
  •  
9.
  • Alsterlund, Rolf, et al. (författare)
  • Yersinia enterocolitica-utbrott på Bjärehalvön visar på risker med kylda matvaror
  • 1995
  • Ingår i: Läkartidningen. - Stockholm : Sveriges läkarförbund. - 0023-7205 .- 1652-7518. ; 92:12, s. 1213-1214
  • Tidskriftsartikel (refereegranskat)abstract
    • På sensommaren 1988 hade man i Skåne ett stort lokalt utbrott med 61 fall av infektioner med Yersinia enterocolitica. DEn kliniska bilden var avsevärt mildare än som brukar rapporteras, med diarré, magsmärtor och feber som dominerande symtom, och endast två fall av svårare komplikationer. Den sannolika smittkällan var mjölk från ett litet mejeri där hygienen inte var den bästa, Utbrottet visar på en av många risker med distribution av industriellt framställda kylda livsmedel.
  •  
10.
  • Amirkhani, Ardeshir, et al. (författare)
  • Comparison between different sheathless electrospray emitter configurations regarding the performance of nanoscale liquid chromatography time-of-flight mass spectrometry analysis
  • 2004
  • Ingår i: Journal of Chromatography A. - : Elsevier BV. - 0021-9673 .- 1873-3778. ; 1033:2, s. 257-266
  • Tidskriftsartikel (refereegranskat)abstract
    • Four different sheathless electrospray ionization (ESI) configurations were investigated for a nano liquid chromatography (LC) system. The studied configurations were: a column with an integrated emitter, with the ESI potential applied before or after the column, and a column with separate emitter, with the ESI voltage applied at a union before the emitter or at the emitter tip. The results indicates that the efficiency of the LC system is rather independent of the configuration when using 95 μm i.d. columns, acetic mobile phase and standard peptides as a sample. Introduction of post column dead volume seems not to be a critical issue at least with flow rates down to 600 nl/min.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-10 av 71
Typ av publikation
tidskriftsartikel (59)
annan publikation (4)
doktorsavhandling (4)
patent (2)
rapport (1)
konferensbidrag (1)
visa fler...
visa färre...
Typ av innehåll
refereegranskat (58)
övrigt vetenskapligt/konstnärligt (9)
populärvet., debatt m.m. (4)
Författare/redaktör
Danielsson, Rolf (39)
Bergquist, Jonas (12)
Danielsson, Åke (12)
Hultcrantz, Rolf (10)
Lindgren, Stefan (10)
Bergquist, Annika (8)
visa fler...
Sandberg-Gertzen, Ha ... (8)
Bäckström, Daniel (8)
Almer, Sven (7)
Wallerstedt, Sven (6)
Sjöberg, Per J.R. (6)
Sangfelt, Per (5)
Bylund, Dan (5)
Adolfsson, Rolf (4)
Bjornsson, Einar (4)
Norrback, Karl-Fredr ... (4)
Werner, Mårten (4)
Weiland, Ola (4)
Lööf, Lars (4)
Borén, Thomas (3)
Turner, Charlotta (3)
Dubois, Andre (3)
Karling, Pontus (3)
Danielsson, Mats, Pr ... (3)
Almer, Sven, 1953- (3)
Larsson, Rolf (2)
Engstrand, Lars (2)
Wickström, Malin (2)
Holgersson, Jan (2)
Ekbom, Anders (2)
Oscarson, Stefan (2)
Nygren, Peter (2)
Liu, Hui (2)
Ohlsson, Bodil (2)
Rydin, Emil (2)
Brännström, Kristoff ... (2)
Bylund, Göran (2)
Ryberg, Per (2)
Ahlgren, Joakim (2)
Eriksson, Per (2)
Aisenbrey, Christoph ... (2)
Gröbner, Gerhard (2)
Unemo, Magnus (2)
Strömberg, Nicklas (2)
Allard, Erik (2)
Alsterlund, Rolf (2)
Danielsson-Tham, Mar ... (2)
Edén, Tony (2)
De Jong, Birgitta (2)
Nilsson, Per Olof (2)
visa färre...
Lärosäte
Uppsala universitet (44)
Umeå universitet (19)
Karolinska Institutet (16)
Linköpings universitet (12)
Lunds universitet (12)
Örebro universitet (6)
visa fler...
Mittuniversitetet (6)
Kungliga Tekniska Högskolan (3)
Göteborgs universitet (2)
Stockholms universitet (2)
RISE (2)
Chalmers tekniska högskola (1)
Linnéuniversitetet (1)
Riksantikvarieämbetet (1)
visa färre...
Språk
Engelska (61)
Svenska (6)
Odefinierat språk (4)
Forskningsämne (UKÄ/SCB)
Naturvetenskap (25)
Medicin och hälsovetenskap (19)
Lantbruksvetenskap (3)
Teknik (2)
Samhällsvetenskap (2)
Humaniora (2)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy